ICSMA-18-107-01: Abbott Laboratories Defibrillator

CISA's summary

Risk evaluation: Successful exploitation of these vulnerabilities may allow a nearby attacker to gain unauthorized access to an ICD to issue commands, change settings, or otherwise interfere with the intended function of the ICD.

Products, as the advisory lists them

DeSpy has not checked any unit, hardware revision or firmware.

Vulnerabilities in this advisory

• CVE-2017-12712 · CWE-287

  The device 's authentication algorithm, which involves an authentication key and time stamp, can be compromised or bypassed, which may allow a nearby attacker to issue unauthorized commands to the ICD or CRT-D via RF communications.CVE-2017-12712 has been assigned to this vulnerability. A CVSS v3 base score of 7.5 has been assigned; the CVSS vector string is (AV:A/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H).

• CVE-2017-12714 · CWE-920

  The ICDs and CRT-Ds do not restrict or limit the number of correctly formatted RF wake-up commands that can be received, which may allow a nearby attacker to repeatedly send commands to reduce device battery life. CVE-2017-12714 has been assigned to this vulnerability. A CVSS v3 base score of 5.3 has been assigned; the CVSS vector string is (AV:A/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:H).. Abbott is a U.S.-based company headquartered in Abbott Park, Illinois. Abbott is a U.S.-based company headquartered in Abbott Park, Illinois.. The affected ICDs and CRT-Ds are implantable medical devices designed to deliver high voltage electrical pulses to correct a fast or irregular heartbeat. According to Abbott, these devices are deployed across the healthcare and public health sector. Abbott indicates that these products are used worldwide.CVE-2017-12714 has been assigned to this vulnerability. A CVSS v3 base score of 5.3 has been assigned; the CVSS vector string is (AV:A/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:H).

Acknowledgments, as the advisory lists them

• MedSec Holdings Ltd: reporting these vulnerabilities to Abbott Laboratories and NCCIC

The advisory's legal notice

All information products included in https://us-cert.cisa.gov/ics are provided "as is" for informational purposes only. The Department of Homeland Security (DHS) does not provide any warranties of any kind regarding any information contained within. DHS does not endorse any commercial product or service, referenced in this product or otherwise. Further dissemination of this product is governed by the Traffic Light Protocol (TLP) marking in the header. For more information about TLP, see https://us-cert.cisa.gov/tlp/.

Sources

• The advisory at cisa.gov
• The CSAF document (JSON)

DeSpy's copy of this version is dated 2026-09-28.